78 related articles for article (PubMed ID: 14737849)
1. [Cardiovascular protective action of Rho-kinase inhibitors].
Hirooka Y
Nihon Rinsho; 2004 Jan; 62(1):161-71. PubMed ID: 14737849
[TBL] [Abstract][Full Text] [Related]
2. Rho-kinase as a potential therapeutic target for the treatment of pulmonary hypertension.
Xing XQ; Gan Y; Wu SJ; Chen P; Zhou R; Xiang XD
Drug News Perspect; 2006 Nov; 19(9):517-22. PubMed ID: 17220956
[TBL] [Abstract][Full Text] [Related]
3. Rho-kinase is an important therapeutic target in cardiovascular medicine.
Shimokawa H; Takeshita A
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1767-75. PubMed ID: 16002741
[TBL] [Abstract][Full Text] [Related]
4. Targeting Rho and Rho-kinase in the treatment of cardiovascular disease.
Budzyn K; Marley PD; Sobey CG
Trends Pharmacol Sci; 2006 Feb; 27(2):97-104. PubMed ID: 16376997
[TBL] [Abstract][Full Text] [Related]
5. Rho kinase inhibitors as potential therapeutic agents for cardiovascular diseases.
Hu E; Lee D
Curr Opin Investig Drugs; 2003 Sep; 4(9):1065-75. PubMed ID: 14582450
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Rho-kinase stimulates nitric oxide-independent vasorelaxation.
Löhn M; Steioff K; Bleich M; Busch AE; Ivashchenko Y
Eur J Pharmacol; 2005 Jan; 507(1-3):179-86. PubMed ID: 15659308
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor gamma ligands inhibit Rho/Rho kinase pathway by inducing protein tyrosine phosphatase SHP-2.
Wakino S; Hayashi K; Kanda T; Tatematsu S; Homma K; Yoshioka K; Takamatsu I; Saruta T
Circ Res; 2004 Sep; 95(5):e45-55. PubMed ID: 15308580
[TBL] [Abstract][Full Text] [Related]
8. RhoA/Rho-kinase pathway: much more than just a modulation of vascular tone. Evidence from studies in humans.
Calò LA; Pessina AC
J Hypertens; 2007 Feb; 25(2):259-64. PubMed ID: 17211228
[TBL] [Abstract][Full Text] [Related]
9. [Rho-Rho kinase pathway].
Takuwa Y
Nihon Rinsho; 2004 Jan; 62(1):43-8. PubMed ID: 14737834
[TBL] [Abstract][Full Text] [Related]
10. Rho-kinase inhibition suppresses bladder hyperactivity in spontaneously hypertensive rats.
Rajasekaran M; Wilkes N; Kuntz S; E Albo M
Neurourol Urodyn; 2005; 24(3):295-300. PubMed ID: 15791631
[TBL] [Abstract][Full Text] [Related]
11. Phosphodiesterase-5 inhibition synergizes rho-kinase antagonism and enhances erectile response in male hypertensive rats.
Wilkes N; White S; Stein P; Bernie J; Rajasekaran M
Int J Impot Res; 2004 Apr; 16(2):187-94. PubMed ID: 15073608
[TBL] [Abstract][Full Text] [Related]
12. [Rho/Rho kinase signal transduction pathway in cardiovascular disease and cardiovascular remodeling].
Jalil J; Lavandero S; Chiong M; Ocaranza MP
Rev Esp Cardiol; 2005 Aug; 58(8):951-61. PubMed ID: 16053829
[TBL] [Abstract][Full Text] [Related]
13. [Rho and Rho-kinase].
Sato J; Iiri T
Nihon Rinsho; 2006 Jul; 64 Suppl 5():197-202. PubMed ID: 16897863
[No Abstract] [Full Text] [Related]
14. Chronic fluvastatin treatment alters vascular contraction by inhibiting the Rho/Rho-kinase pathway.
Kansui Y; Fujii K; Goto K; Oniki H; Iida M
Clin Exp Pharmacol Physiol; 2006 Aug; 33(8):673-8. PubMed ID: 16895538
[TBL] [Abstract][Full Text] [Related]
15. Rho/Rho-kinase pathway contributes to C-reactive protein-induced plasminogen activator inhibitor-1 expression in endothelial cells.
Nakakuki T; Ito M; Iwasaki H; Kureishi Y; Okamoto R; Moriki N; Kongo M; Kato S; Yamada N; Isaka N; Nakano T
Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2088-93. PubMed ID: 16123329
[TBL] [Abstract][Full Text] [Related]
16. Involvement of Rho/Rho kinase pathway in regulation of apoptosis in rat hepatic stellate cells.
Ikeda H; Nagashima K; Yanase M; Tomiya T; Arai M; Inoue Y; Tejima K; Nishikawa T; Omata M; Kimura S; Fujiwara K
Am J Physiol Gastrointest Liver Physiol; 2003 Nov; 285(5):G880-6. PubMed ID: 12829436
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
[TBL] [Abstract][Full Text] [Related]
18. [Role of Rho/Rho-kinase pathway in angiotensin II signaling].
Ichiki T
Nihon Rinsho; 2002 Oct; 60(10):1929-34. PubMed ID: 12397686
[TBL] [Abstract][Full Text] [Related]
19. Defective RhoA/Rho-kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats.
Hennenberg M; Biecker E; Trebicka J; Jochem K; Zhou Q; Schmidt M; Jakobs KH; Sauerbruch T; Heller J
Gastroenterology; 2006 Mar; 130(3):838-54. PubMed ID: 16530523
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of rho-kinase inhibitors in cardiovascular diseases.
Hirooka Y; Shimokawa H
Am J Cardiovasc Drugs; 2005; 5(1):31-9. PubMed ID: 15631536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
